| Bioactivity | Aβ-IN-9 (Compound 6i) is an amyloid-beta aggregation inhibitor. Aβ-IN-9 can inhibit Aβ aggregation to form nano-rod-like structures, thereby preventing β-sheet formation. Aβ-IN-9 can be used for Alzheimer's disease research[1]. |
| Formula | C17H17NO5 |
| Molar Mass | 315.32 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Xu F, et al. Synthesis and evaluation of catecholamine derivatives as amyloid-beta aggregation inhibitors. Bioorg Med Chem Lett. 2024 Jul 15;107:129788. |